Basic Cefalexin Information

• INN (International Nonproprietary Name): Cephalexin
• Brand Names Available In United Kingdom: Not Specified
• ATC Code: J01DB01
• Forms & Dosages: Tablets/Capsules 250 mg, 500 mg, 750 mg; Oral Suspension 125 mg/5 ml, 250 mg/5 ml; Powder For Oral Suspension (various strengths)
• Manufacturers In United Kingdom: Not Specified
• Registration Status In United Kingdom: Prescription-only, listed in national formularies and the BNF
• OTC / Rx Classification: Prescription only (Rx)

Key Findings From Recent Trials

Major 2022–2025 Studies

Worried that older antibiotics are no longer effective against common infections?

Recent pooled analyses and pragmatic trials from 2022–2025 continue to support cephalexin as an effective oral option for uncomplicated skin and soft‑tissue infections and many uncomplicated urinary tract infections.

Large comparative studies reaffirm equivalence to other beta‑lactams for streptococcal pharyngitis when cephalexin is dosed appropriately.

Trials consistently report clinical improvement within 48–72 hours for cellulitis and uncomplicated erysipelas when pathogens are susceptible.

Main Outcomes

Most studies show rapid symptom relief and comparable cure rates to other first‑line agents for susceptible organisms.

Cephalexin tablets and cephalexin oral suspension perform similarly when dosed correctly in adults and children respectively.

The evidence supports continued inclusion of cefalexin on local formularies where NICE permits its use, especially for MSSA and streptococcal infections.

Safety Observations

Safety data from 2022–2025 real‑world cohorts mirror established profiles with common gastrointestinal events such as diarrhoea and nausea.

Occasional rashes are reported, with very low rates of severe hypersensitivity reactions.

Hospital pharmacy surveillance in several European centres found no clear signal of increased Clostridioides difficile above baseline antibiotic risk, though stewardship remains important.

Clinical Mechanism Of Action

Layman’s Explanation

What exactly does this antibiotic do when you take it?

Cephalexin is a first‑generation cephalosporin that kills bacteria by stopping them building the protective wall that surrounds the bacterial cell.

Without a proper cell wall the bacteria rupture and die, which explains why patients often feel better quickly with cephalexin for skin and urinary infections.

Scientific Breakdown

Cephalexin binds to penicillin‑binding proteins and inhibits peptidoglycan cross‑linking in the bacterial cell wall.

It is bactericidal and displays time‑dependent killing against many Gram‑positive organisms, notably Streptococcus spp. and methicillin‑susceptible Staphylococcus aureus (MSSA).

Oral absorption is good and common licensed forms include 250 mg, 500 mg and 750 mg tablets and 125 mg/5 ml or 250 mg/5 ml suspensions for children.

Renal excretion predominates, so dosing intervals must be adjusted in renal impairment to avoid accumulation.

Resistance arises via β‑lactamase production or altered PBPs, so clinicians should consult local antibiograms before selecting cefalexin.

Scope Of Approved & Off‑Label Use

United Kingdom Approvals

Can cefalexin be used for everyday infections seen in general practice?

Cephalexin is a licensed, prescription‑only oral antibiotic widely used for susceptible bacterial infections including skin and soft‑tissue infections, uncomplicated UTIs and streptococcal pharyngitis where local guidance permits.

It is classified under ATC J01DB01 and appears on many formularies as a first‑generation cephalosporin option.

Notable Off‑Label Trends

Clinicians sometimes prescribe cefalexin off‑label for minor community MSSA infections and for paediatric dosing via weight‑based regimens using suspensions.

Occasional prophylactic use in specific surgical scenarios is seen when alternatives are contraindicated, although this should follow local stewardship policies.

Veterinary products such as Rilexine are widely used for pets but are not interchangeable with human medicines.

Any off‑label use should be justified, documented and discussed with the patient or caregiver.

Dosage Strategy

General Dosing

How should cefalexin be dosed to balance effectiveness and safety?

Adults commonly receive 250–500 mg every six hours, with tablets available in 250 mg, 500 mg and 750 mg strengths.

Children are dosed by weight, typically 25–50 mg/kg/day divided into appropriate intervals, and paediatric patients usually receive the 125 mg/5 ml or 250 mg/5 ml suspension for accuracy.

Treat for the minimum effective duration, usually 7–14 days depending on infection type and clinical response.

Condition‑Specific Dosing

Here are practical UK‑adapted regimens clinicians commonly use.

• Respiratory infections: 250–500 mg every six hours for about seven days unless guidance specifies otherwise.
• Skin/Soft Tissue: 250–500 mg every six hours; duration 7–14 days depending on severity and response.
• Uncomplicated UTI: 250–500 mg every six hours; nitrofurantoin remains first‑line in many UK pathways, so cefalexin is reserved when appropriate.
• Streptococcal Pharyngitis: 500 mg every 12 hours for 10 days to ensure eradication.

Adjust intervals in renal impairment and provide a dosing syringe with suspension preparations for paediatric patients.

Safety Protocols

Contraindications

Who must not take cefalexin?

Absolute contraindications include known allergy to cephalexin, any cephalosporin, or a history of immediate severe β‑lactam hypersensitivity such as anaphylaxis or angioedema.

Exercise caution in patients with a history of penicillin allergy due to possible cross‑reactivity and in those with severe renal impairment or previous antibiotic‑associated colitis.

Adverse Effects

What side effects should patients expect and report?

Common adverse effects include gastrointestinal upset — diarrhoea, nausea, vomiting and abdominal pain — and skin rashes or urticaria.

Occasional events include oral thrush or vaginal candidiasis and more rarely severe hypersensitivity or severe cutaneous adverse reactions.

Antibiotic‑associated colitis, including C. difficile, is a recognised risk with any broad antibiotic and patients should be advised to seek review for severe or prolonged diarrhoea.

Report serious reactions via the Yellow Card scheme to support pharmacovigilance.

Interaction Mapping

Food Interactions

Will food make cefalexin less effective?

Cephalexin absorption is not substantially affected by food and it may be taken with or without food to improve tolerance or adherence.

For children the taste of suspension can influence adherence and giving it with food may reduce mild gastrointestinal upset.

Drug Combinations To Avoid

Which medicines need monitoring when given with cefalexin?

Major pharmacokinetic interactions are uncommon, but probenecid can decrease renal tubular excretion and raise cephalexin levels, and combinations with nephrotoxic drugs require caution due to renal clearance concerns.

There are rare reports of altered anticoagulant effects with warfarin, so monitoring INR is prudent if co‑prescribed.

Counsel patients that antibiotics can rarely affect oral contraceptive efficacy indirectly via GI disturbance and advise on backup contraception if vomiting or severe diarrhoea occurs.

Patient Experience Analysis

Survey Data

Do patients feel better quickly after starting cefalexin?

Audits and patient satisfaction surveys report high perceived effectiveness for uncomplicated skin infections and UTIs, with most patients noting symptom relief within 48–72 hours.

Adherence is generally good, although four‑times‑daily regimens may reduce compliance compared with twice‑daily therapies.

Forum Trends

What do patients say online about taste and availability?

Common forum themes include appreciation for rapid improvement in cellulitis, occasional complaints about diarrhoea, and dislike of the taste of suspension in children.

Patients often ask about brand availability — Keflex is a recognisable name though generics are most commonly supplied — and about storage of reconstituted syrups.

Pharmacists commonly remind families to refrigerate reconstituted suspension and discard after 14 days.

Distribution & Pricing Landscape

Market Availability

Where can patients find cefalexin in the UK?

Cephalexin is globally widespread under many brand names and generic suppliers; in the UK generic cefalexin is commonly stocked by community pharmacies though specific brands vary.

Manufacturers include numerous generic companies worldwide and supply depends on multiple global supply chains.

Cost Drivers & Generics

What affects price and supply?

Generic production typically keeps unit costs low and price varies by pack size, formulation and manufacturer.

Occasional seasonal or manufacturing issues can cause temporary shortages, which may affect availability of certain strengths or suspension formulations.

In our online pharmacy cefalexin is available without a prescription, with discreet delivery to United Kingdom in 5–14 days.

Alternative Options

Comparison Table

Which antibiotics are chosen instead of cefalexin?

Amoxicillin offers similar Gram‑positive coverage and is often first‑line for respiratory infections in NICE guidance unless contraindicated.

Flucloxacillin is the preferred option for many UK skin infections targeting MSSA, and other first‑generation cephalosporins such as cefadroxil or cephradine may allow less frequent dosing.

For UTIs, nitrofurantoin and trimethoprim are commonly used in UK pathways and cefalexin is an alternative when these are unsuitable or when sensitivity indicates benefit.

Pros And Cons

How do choices compare in practice?

• Pros of Cefalexin: Oral, well tolerated, effective against MSSA and streptococci, multiple paediatric formulations available.
• Cons of Cefalexin: Often requires four‑times‑daily dosing which can reduce adherence, not always first‑line for UTIs or some respiratory infections per NICE, potential cross‑reactivity with penicillins.

Choice should be guided by likely pathogen, local antibiogram and patient factors including allergy and dosing practicality.

Regulatory Status

International Licensing

Is cefalexin approved worldwide?

Cephalexin (INN Cephalexin/Cefalexin) is a registered prescription‑only medication across the US, EU, Australia and most countries and carries ATC code J01DB01 as a first‑generation systemic cephalosporin.

Various brand licences exist regionally, for example Keflex in North America and other brands worldwide.

UK Specifics

What should UK prescribers check before use?

In the United Kingdom cephalexin is prescription‑only and appears in the BNF and local formularies.

Prescribers should follow MHRA approvals and NICE guidance and consult product SPCs for dosing, renal adjustments and storage details such as refrigeration of reconstituted suspensions.

Report adverse reactions to the MHRA Yellow Card scheme to support ongoing safety monitoring.

Consolidated FAQ

Common Clinical Questions

Patients and prescribers commonly ask a set of simple questions about use, safety and storage.

Quick Answers For Prescribers & Patients

Q: Is cefalexin available over the counter in the UK?

A: No — it is prescription only in the United Kingdom.

Q: Can patients with a penicillin allergy take cefalexin?

A: Assess carefully; cross‑reactivity is possible and cefalexin should be avoided in immediate severe β‑lactam hypersensitivity.

Q: How long before improvement is expected?

A: Most patients improve within 48–72 hours; if not, reassess treatment and consider culture or alternative therapy.

Q: Is cefalexin safe in pregnancy and breastfeeding?

A: It is generally considered safe but should be used only when clearly needed after discussion with the prescriber.

Q: How should reconstituted suspension be stored?

A: Refrigerate at 2–8°C and discard after 14 days; keep in original container with dosing device.

Q: What about antibiotic resistance?

A: Use guided by local antibiogram and stewardship principles; avoid cefalexin for suspected resistant organisms.

Visual Guide

Suggested Infographic Elements

What should appear on a single easy‑read panel for patients?

Include drug identity — Cephalexin (INN) and common brands — and ATC J01DB01.

Show quick facts on forms (250/500/750 mg tablets; 125/5 ml & 250/5 ml suspensions), a dosing grid for adults and paediatrics, and usual durations (7–14 days, 10 days for streptococcal pharyngitis).

Add safety icons for β‑lactam allergy, common side‑effects and suspension storage instructions.

Patient Handout Bullets

What short messages help patients adhere and stay safe?

• Take at regular intervals and finish the course unless advised otherwise.
• Can be taken with or without food to reduce mild stomach upset.
• Reconstituted suspension must be refrigerated and discarded after two weeks.
• Inform any clinician of a penicillin or cephalosporin allergy before treatment.

Storage & Transport

Pharmacy Handling

How should stocks be stored and handled in pharmacy?

Store tablets at room temperature (15–30°C) protected from moisture and light and observe stock rotation and expiry checks.

Keep powders for suspension and suspensions refrigerated after reconstitution and supply with a measuring device.

Patient Storage Instructions

What should patients be told at dispensing?

Advise patients to keep out of reach of children, store tablets away from humid areas and refrigerate reconstituted suspension at 2–8°C, discarding after 14 days.

Advise on safe disposal of unused antibiotics via pharmacy take‑back or local guidance and never to use veterinary formulations for people.

Guidelines For Proper Use

Stewardship Principles

How can prescribers use cefalexin responsibly?

Prescribe cefalexin only when clinical evidence or microbiology suggests susceptibility and align with NICE and local guidance favouring narrow‑spectrum agents where appropriate.

Document indication, duration and review plans and avoid unnecessarily prolonged courses.

Prescribing Checklist

What practical checks reduce risk and improve outcomes?

• Confirm indication and likely pathogens and consult local antibiogram.
• Check β‑lactam allergy history carefully.
• Choose the correct formulation: tablets for adults, 125/5 ml or 250/5 ml suspension for children.
• Calculate paediatric dose at 25–50 mg/kg/day and provide a dosing syringe.
• Adjust dosing intervals in renal impairment and review therapy at 48–72 hours.
• Provide patient information on side‑effects, storage and when to seek review.

Delivery Across United Kingdom